[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2002]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR14.30]

[Page 156]
 
                        TITLE 21--FOOD AND DRUGS
 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN 
                                SERVICES
 
PART 14--PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE--Table of Contents
 
                      Subpart B--Meeting Procedures
 
Sec. 14.30  Chairman of an advisory committee.

    (a) The advisory committee chairman has the authority to conduct 
hearings and meetings, including the authority to adjourn a hearing or 
meeting if the chairman determines that adjournment is in the public 
interest, to discontinue discussion of a matter, to conclude the open 
portion of a meeting, or to take any other action to further a fair and 
expeditious hearing or meeting.
    (b) If the chairman is not a full-time employee of FDA, the 
executive secretary or other designated agency employee, or alternate, 
is to be the designated Federal employee who is assigned to the advisory 
committee. The designated Federal employee is also authorized to adjourn 
a hearing or meeting if the employee determines adjournment to be in the 
public interest.